Arcoma AB (ARCOMA) - Total Liabilities

Latest as of September 2025: Skr24.58 Million SEK ≈ $2.64 Million USD

Based on the latest financial reports, Arcoma AB (ARCOMA) has total liabilities worth Skr24.58 Million SEK (≈ $2.64 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Arcoma AB net asset momentum to track the company's year-over-year net asset growth rate.

Arcoma AB - Total Liabilities Trend (2012–2024)

This chart illustrates how Arcoma AB's total liabilities have evolved over time, based on quarterly financial data. See Arcoma AB free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Arcoma AB Competitors by Total Liabilities

The table below lists competitors of Arcoma AB ranked by their total liabilities.

Company	Country	Total Liabilities
Cocrystal Pharma Inc NASDAQ:COCP	USA	$3.31 Million
Tempest Therapeutics Inc NASDAQ:TPST	USA	$9.93 Million
Thunderful Group AB ST:THUNDR	Sweden	Skr172.90 Million
Kainos Group PLC LSE:KNOS	UK	GBX164.47 Million
New Nordic Healthbrands AB (publ) ST:NNH	Sweden	Skr162.35 Million
Flour Mills Kepenos S.A. AT:KEPEN	Greece	€45.05 Million
FingerMotion Inc NASDAQ:FNGR	USA	$45.70 Million
DB (International) Stock Brokers Limited NSE:DBSTOCKBRO	India	Rs402.88 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Arcoma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Arcoma AB.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcoma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcoma AB (2012–2024)

The table below shows the annual total liabilities of Arcoma AB from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr21.13 Million ≈ $2.27 Million	-36.56%
2023-12-31	Skr33.30 Million ≈ $3.58 Million	-38.84%
2022-12-31	Skr54.46 Million ≈ $5.86 Million	+54.57%
2021-12-31	Skr35.23 Million ≈ $3.79 Million	-22.57%
2020-12-31	Skr45.50 Million ≈ $4.90 Million	+19.28%
2019-12-31	Skr38.14 Million ≈ $4.10 Million	+2.43%
2018-12-31	Skr37.24 Million ≈ $4.01 Million	+36.52%
2017-12-31	Skr27.28 Million ≈ $2.94 Million	-19.55%
2016-12-31	Skr33.90 Million ≈ $3.65 Million	-1.26%
2015-12-31	Skr34.34 Million ≈ $3.69 Million	-8.40%
2014-12-31	Skr37.48 Million ≈ $4.03 Million	-35.77%
2013-12-31	Skr58.35 Million ≈ $6.28 Million	+31.57%
2012-12-31	Skr44.35 Million ≈ $4.77 Million	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$12.93 Million

Skr120.19 Million SEK

Market Cap Rank

#26366 Global

#564 in Sweden

Share Price

Skr8.40

Change (1 day)

-6.46%

52-Week Range

Skr6.92 - Skr9.80

All Time High

Skr25.60